IMNP
Morgan Stanley’s Immune Pharmaceuticals Inc. IMNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3
| Closed | – | – | 6975 |
|
|
2018
Q2 | $0 | Sell |
3
-2,746
| -100% | – | ﹤0.01% | 6866 |
|
|
2018
Q1 | $1K | Buy |
2,749
+2,695
| +4,991% | +$980 | ﹤0.01% | 6582 |
|
|
2017
Q4 | $0 | Buy |
54
+49
| +980% | – | ﹤0.01% | 6781 |
|
|
2017
Q3 | $0 | Buy |
5
+1
| +25% | – | ﹤0.01% | 6700 |
|
|
2017
Q2 | $0 | Sell |
4
-96
| -96% | – | ﹤0.01% | 6732 |
|
|
2017
Q1 | $0 | Buy |
+100
| New | – | ﹤0.01% | 6675 |
|
|
2016
Q3 | – | Sell |
-69
| Closed | – | – | 6621 |
|
|
2016
Q2 | $0 | Buy |
69
+11
| +19% | – | ﹤0.01% | 6792 |
|
|
2016
Q1 | $0 | Buy |
58
+6
| +12% | – | ﹤0.01% | 6850 |
|
|
2015
Q4 | $0 | Buy |
+52
| New | – | ﹤0.01% | 6918 |
|
|
2015
Q3 | – | Sell |
-41
| Closed | – | – | 6832 |
|
|
2015
Q2 | $0 | Buy |
41
+1
| +3% | – | ﹤0.01% | 6847 |
|
|
2015
Q1 | $0 | Sell |
40
-86
| -68% | – | ﹤0.01% | 6751 |
|
|
2014
Q4 | $0 | Sell |
126
-10,077
| -99% | – | ﹤0.01% | 6762 |
|
|
2014
Q3 | $35K | Buy |
+10,203
| New | +$35K | ﹤0.01% | 5840 |
|